Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mid Cap SPDR 400 Trust, Series 1 (NY: MDY )

453.68 +2.79 (+0.62%)
Official Closing Price Updated: 8:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mid Cap SPDR 400 Trust, Series 1

< Previous 1 2 Next >
Does Ciena's Earnings Beat Signal New Networking Boom Ahead?
Network gear maker Ciena saw a sizeable gap-up in stock price after strong Q3 earnings. What does that say about prospects for the broader industry? 
Via MarketBeat
Topics Artificial Intelligence Earnings
Exposures Artificial Intelligence Financial
New Stock Signals Say Long-Term Opportunity For Investors
Several monthly stock market signals were nailed down at the end of August. 
Via Talk Markets
Investment Strategies: Who Is Winning In The Battle Of Active Vs Passive Investors
It’s worth noting that over 50% of U.S. Large-Cap active managers underperformed the S&P 500 in 18 of the past 21 years. Furthermore, this underperformance escalates significantly with an extended... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Here's Exactly How I'll Make Over $18,000 in Dividend Income This Year
Even investments with lower yields can generate significant dividend income. 
Via The Motley Fool
ETF Focus: Majors
Let’s look at some of the biggest ETFs after this horrific week for bears. 
Via Talk Markets
2023 Midyear Review Of Index ETFs And Smart Beta Strategies & A Tribute To Harry Markowitz
A review and analysis of the first 6 months of 2023 using benchmark ETFs, Sector ETFs, and Smart Beta ETFs and what is likely to follow next. 
Via Talk Markets
Small Caps Are Starting To Work—and We’re Likely Still Early
Over the past month, the S&P 600 Index has jumped over 8% - a sign that small-cap stocks are finally starting to work. 
Via Talk Markets
3 ETFs That Can Supercharge Your Retirement Savings
You don't have to take big risks with individual stocks to amp up your overall returns. 
Via The Motley Fool
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Kinsale Capital Group beat Wall Street views, spurring price outperformance relative to other insurers and its mid-cap index. Institutions are buying shares. 
Via MarketBeat
Emcor Stock in Buy Zone As it Rebounds Off 50-Day Average
Emcor Group shows strong buying support as it bounces off its 50-day average. The stock is outperforming its index as earnings growth accelerates. 
Via MarketBeat
Topics ETFs
Memorial Weekend ETFs: The Core
The small caps have been grinding away for a full year in a relatively tight range. There is a head and shoulders pattern in the midst of all that grinding, but it has not broken its neckline. 
Via Talk Markets
Shockwave Medical, Fast Grower, In Boston Scientific's Sights?
Shockwave earnings are growing at triple-digit rates. The company easily beat Q1 views. Boston Scientific is reportedly interested in acquiring Shockwave. 
Via MarketBeat
Topics ETFs
Analysts Have "Buy" Rating On This Mid-Cap Dividend Achiever
Mid-cap industrial-sector stock Donaldson is a steady gainer, returning 32.44% in the past year. It has a 36-year track record of increasing its dividend. 
Via MarketBeat
Texas Roadhouse: Analysts Boost Price Targets Despite EPS Miss
Texas Roadhouse found support at its 50-day average after missing Q1 earnings views. The company reiterated expectations for sales growth this year. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Is Mid-Cap Hubbell The Right Stock To Electrify Your Portfolio?
Hubbell stock is trading at new highs following better-than-expected Q1 results. Wall Street sees the company growing earnings by 27% this year. 
Via MarketBeat
Topics ETFs Supply Chain
Exposures Supply Chain
April & Q2 Setting Up Nicely For The Bulls But Concerns Remain
Let’s focus on April and what it seasonally brings to the stock market. 
Via Talk Markets
Nasdaq Leaves The S&P In The Dust
Looking at the major US index ETFs shows just how disconnected the Nasdaq 100 has become from other major index ETFs recently. 
Via Talk Markets
Cabot Boosting Production In Lithium Battery Chain For EV Market
Chemical maker Cabot is growing to meet demand for materials to produce lithium-ion batteries. It may offer a buy opportunity on a moving-average pullback. 
Via MarketBeat
Topics ETFs
Keys To A Massive Week For Bulls & Bears
With the latest read on inflation coming next week, in the form of CPI, here are the key stock market developments to monitor. 
Via Talk Markets
4 Index Funds I Predict Will Beat the Market in 2023
Contrary to common belief, you don't have to trade individual stocks to outperform the overall stock market. 
Via The Motley Fool
Rotating Regimes – What To Plan For In 2023
Throughout the second half of 2022, active managers turned to sector rotation to help mitigate and recover from substantial losses incurred already. Rotation into and out of low and high volatility... 
Via Talk Markets
Are New Bull Market Leaders Emerging?
The drivers of poor investment performance in 2022 may have set the table for new leadership in the next bull market. 
Via Talk Markets
200-Day Moving Average: Your Key, “Must-Follow” Stock Market Indicator In 2023
Are you tired of making costly mistakes when buying stocks stuck in a downtrend? Look no further than the 200-day moving average. Here, we explore the 200-day moving average, including how it works,... 
Via Talk Markets
ETF Battles: Large Caps Vs. Mid Caps Vs. Small Caps - Who Wins?
In this episode of ETF Battles, Ron DeLegge @etfguide referees a market cap size investing contest between SPY, MDY and SLY from State Street Global Advisors. 
Via Talk Markets
Equal-Weight ETFs Win Over Market-Cap Peers In 2022
Though the decline was broad-based, equal-weighted ETFs are performing better than their market-cap counterparts. 
Via Talk Markets
7 Index Funds to Buy to Retire a Millionaire
Although the market shows signs of improvement, the waters are still choppy enough for investors to focus on index funds to buy. 
Via InvestorPlace
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel. 
Via MarketBeat
Can Mid-Cap Lantheus Continue its 2022 Outperformance?
Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test. 
Via MarketBeat
Topics ETFs Initial Public Offering
Exposures Securities Market
Opportunities In Large Cap Growth And Small Cap
The third quarter was true 
Via Talk Markets
3 Stocks With Market-Beating Price Performance
Digi International, Lamb Weston Holdings, and Wingstop traded higher in heavy trading volume,. Mid-caps are outperforming the S&P 500 large-cap index this year. 
Via MarketBeat
Topics ETFs Stocks
Exposures US Equities
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.